Viewing Opinion | StockChase
Helius Medical Technologies (HSM-T) opinion on 2017-02-16

Last Price Recorded: 3.1000 on 2017-11-23

ON STOCKCHASE SINCE Apr 2016

Healthcare
SPECULATIVE BUY

Fabrice Taylor
Helius Medical Technologies was $2.150 at time of opinion
Owned : Unknown

The odds for shareholders have improved.  They are in FDA trials.  They are speculative and make no money.  He likens it to a lottery ticket or better, to a raffle ticket as the odds are better. 

SELECTIVE

All opinions for HSM-T (9)

1 COMMENT
1 PAST TOP PICK
4 SPECULATIVE BUY
2 TOP PICK
1 WATCH
View All

More experts covering HSM-T

SAVE
Add HSM-T to Watch List

All opinions for HSM-T (9)

1 COMMENT
1 PAST TOP PICK
4 SPECULATIVE BUY
2 TOP PICK
1 WATCH
View All

More experts covering HSM-T

SAVE
Add HSM-T to Watch List

No Comments.


You must be logged in to comment.

Successfully Saved Company